Global New Psychoactive Substance Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global New Psychoactive Substance Market Size 2017-2028

2.1.2 New Psychoactive Substance Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 New Psychoactive Substance Segment by Type

2.2.1 Stimulants

2.2.2 Cannabinoids

2.2.3 Hallucinogens

2.2.4 Depressants

2.3 New Psychoactive Substance Market Size by Type

2.3.1 New Psychoactive Substance Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global New Psychoactive Substance Market Size Market Share by Type (2017-2022)

2.4 New Psychoactive Substance Segment by Application

2.4.1 Cancer

2.4.2 Neuropathic Disorders

2.4.3 Spasticity

2.4.4 Others

2.5 New Psychoactive Substance Market Size by Application

2.5.1 New Psychoactive Substance Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global New Psychoactive Substance Market Size Market Share by Application (2017-2022)

3 New Psychoactive Substance Market Size by Player

3.1 New Psychoactive Substance Market Size Market Share by Players

3.1.1 Global New Psychoactive Substance Revenue by Players (2020-2022)

3.1.2 Global New Psychoactive Substance Revenue Market Share by Players (2020-2022)

3.2 Global New Psychoactive Substance Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 New Psychoactive Substance by Regions

4.1 New Psychoactive Substance Market Size by Regions (2017-2022)

4.2 Americas New Psychoactive Substance Market Size Growth (2017-2022)

4.3 APAC New Psychoactive Substance Market Size Growth (2017-2022)

4.4 Europe New Psychoactive Substance Market Size Growth (2017-2022)

4.5 Middle East & Africa New Psychoactive Substance Market Size Growth (2017-2022)

5 Americas

5.1 Americas New Psychoactive Substance Market Size by Country (2017-2022)

5.2 Americas New Psychoactive Substance Market Size by Type (2017-2022)

5.3 Americas New Psychoactive Substance Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC New Psychoactive Substance Market Size by Region (2017-2022)

6.2 APAC New Psychoactive Substance Market Size by Type (2017-2022)

6.3 APAC New Psychoactive Substance Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe New Psychoactive Substance by Country (2017-2022)

7.2 Europe New Psychoactive Substance Market Size by Type (2017-2022)

7.3 Europe New Psychoactive Substance Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa New Psychoactive Substance by Region (2017-2022)

8.2 Middle East & Africa New Psychoactive Substance Market Size by Type (2017-2022)

8.3 Middle East & Africa New Psychoactive Substance Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global New Psychoactive Substance Market Forecast

10.1 Global New Psychoactive Substance Forecast by Regions (2023-2028)

10.1.1 Global New Psychoactive Substance Forecast by Regions (2023-2028)

10.1.2 Americas New Psychoactive Substance Forecast

10.1.3 APAC New Psychoactive Substance Forecast

10.1.4 Europe New Psychoactive Substance Forecast

10.1.5 Middle East & Africa New Psychoactive Substance Forecast

10.2 Americas New Psychoactive Substance Forecast by Country (2023-2028)

10.2.1 United States New Psychoactive Substance Market Forecast

10.2.2 Canada New Psychoactive Substance Market Forecast

10.2.3 Mexico New Psychoactive Substance Market Forecast

10.2.4 Brazil New Psychoactive Substance Market Forecast

10.3 APAC New Psychoactive Substance Forecast by Region (2023-2028)

10.3.1 China New Psychoactive Substance Market Forecast

10.3.2 Japan New Psychoactive Substance Market Forecast

10.3.3 Korea New Psychoactive Substance Market Forecast

10.3.4 Southeast Asia New Psychoactive Substance Market Forecast

10.3.5 India New Psychoactive Substance Market Forecast

10.3.6 Australia New Psychoactive Substance Market Forecast

10.4 Europe New Psychoactive Substance Forecast by Country (2023-2028)

10.4.1 Germany New Psychoactive Substance Market Forecast

10.4.2 France New Psychoactive Substance Market Forecast

10.4.3 UK New Psychoactive Substance Market Forecast

10.4.4 Italy New Psychoactive Substance Market Forecast

10.4.5 Russia New Psychoactive Substance Market Forecast

10.5 Middle East & Africa New Psychoactive Substance Forecast by Region (2023-2028)

10.5.1 Egypt New Psychoactive Substance Market Forecast

10.5.2 South Africa New Psychoactive Substance Market Forecast

10.5.3 Israel New Psychoactive Substance Market Forecast

10.5.4 Turkey New Psychoactive Substance Market Forecast

10.5.5 GCC Countries New Psychoactive Substance Market Forecast

10.6 Global New Psychoactive Substance Forecast by Type (2023-2028)

10.7 Global New Psychoactive Substance Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Zynerba Pharmaceuticals

11.1.1 Zynerba Pharmaceuticals Company Information

11.1.2 Zynerba Pharmaceuticals New Psychoactive Substance Product Offered

11.1.3 Zynerba Pharmaceuticals New Psychoactive Substance Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Zynerba Pharmaceuticals Main Business Overview

11.1.5 Zynerba Pharmaceuticals Latest Developments

11.2 GW Pharmaceuticals

11.2.1 GW Pharmaceuticals Company Information

11.2.2 GW Pharmaceuticals New Psychoactive Substance Product Offered

11.2.3 GW Pharmaceuticals New Psychoactive Substance Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 GW Pharmaceuticals Main Business Overview

11.2.5 GW Pharmaceuticals Latest Developments

11.3 Teewinot Life Sciences

11.3.1 Teewinot Life Sciences Company Information

11.3.2 Teewinot Life Sciences New Psychoactive Substance Product Offered

11.3.3 Teewinot Life Sciences New Psychoactive Substance Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Teewinot Life Sciences Main Business Overview

11.3.5 Teewinot Life Sciences Latest Developments

11.4 AusCann

11.4.1 AusCann Company Information

11.4.2 AusCann New Psychoactive Substance Product Offered

11.4.3 AusCann New Psychoactive Substance Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 AusCann Main Business Overview

11.4.5 AusCann Latest Developments

11.5 Cannabics Pharmaceuticals

11.5.1 Cannabics Pharmaceuticals Company Information

11.5.2 Cannabics Pharmaceuticals New Psychoactive Substance Product Offered

11.5.3 Cannabics Pharmaceuticals New Psychoactive Substance Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Cannabics Pharmaceuticals Main Business Overview

11.5.5 Cannabics Pharmaceuticals Latest Developments

11.6 Tilray

11.6.1 Tilray Company Information

11.6.2 Tilray New Psychoactive Substance Product Offered

11.6.3 Tilray New Psychoactive Substance Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Tilray Main Business Overview

11.6.5 Tilray Latest Developments

11.7 Cyrelian

11.7.1 Cyrelian Company Information

11.7.2 Cyrelian New Psychoactive Substance Product Offered

11.7.3 Cyrelian New Psychoactive Substance Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Cyrelian Main Business Overview

11.7.5 Cyrelian Latest Developments

11.8 Anandia Laboratories

11.8.1 Anandia Laboratories Company Information

11.8.2 Anandia Laboratories New Psychoactive Substance Product Offered

11.8.3 Anandia Laboratories New Psychoactive Substance Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Anandia Laboratories Main Business Overview

11.8.5 Anandia Laboratories Latest Developments

11.9 InMed Pharmaceuticals

11.9.1 InMed Pharmaceuticals Company Information

11.9.2 InMed Pharmaceuticals New Psychoactive Substance Product Offered

11.9.3 InMed Pharmaceuticals New Psychoactive Substance Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 InMed Pharmaceuticals Main Business Overview

11.9.5 InMed Pharmaceuticals Latest Developments

11.10 Renew Biopharma

11.10.1 Renew Biopharma Company Information

11.10.2 Renew Biopharma New Psychoactive Substance Product Offered

11.10.3 Renew Biopharma New Psychoactive Substance Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Renew Biopharma Main Business Overview

11.10.5 Renew Biopharma Latest Developments

11.11 Cronos Group

11.11.1 Cronos Group Company Information

11.11.2 Cronos Group New Psychoactive Substance Product Offered

11.11.3 Cronos Group New Psychoactive Substance Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Cronos Group Main Business Overview

11.11.5 Cronos Group Latest Developments

11.12 ICC International Cannabis

11.12.1 ICC International Cannabis Company Information

11.12.2 ICC International Cannabis New Psychoactive Substance Product Offered

11.12.3 ICC International Cannabis New Psychoactive Substance Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 ICC International Cannabis Main Business Overview

11.12.5 ICC International Cannabis Latest Developments

11.13 Biotii Technologies

11.13.1 Biotii Technologies Company Information

11.13.2 Biotii Technologies New Psychoactive Substance Product Offered

11.13.3 Biotii Technologies New Psychoactive Substance Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Biotii Technologies Main Business Overview

11.13.5 Biotii Technologies Latest Developments

12 Research Findings and Conclusion

Table 1. New Psychoactive Substance Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Stimulants

Table 3. Major Players of Cannabinoids

Table 4. Major Players of Hallucinogens

Table 5. Major Players of Depressants

Table 6. New Psychoactive Substance Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 7. Global New Psychoactive Substance Market Size by Type (2017-2022) & ($ Millions)

Table 8. Global New Psychoactive Substance Market Size Market Share by Type (2017-2022)

Table 9. New Psychoactive Substance Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 10. Global New Psychoactive Substance Market Size by Application (2017-2022) & ($ Millions)

Table 11. Global New Psychoactive Substance Market Size Market Share by Application (2017-2022)

Table 12. Global New Psychoactive Substance Revenue by Players (2020-2022) & ($ Millions)

Table 13. Global New Psychoactive Substance Revenue Market Share by Player (2020-2022)

Table 14. New Psychoactive Substance Key Players Head office and Products Offered

Table 15. New Psychoactive Substance Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 16. New Products and Potential Entrants

Table 17. Mergers & Acquisitions, Expansion

Table 18. Global New Psychoactive Substance Market Size by Regions 2017-2022 & ($ Millions)

Table 19. Global New Psychoactive Substance Market Size Market Share by Regions (2017-2022)

Table 20. Americas New Psychoactive Substance Market Size by Country (2017-2022) & ($ Millions)

Table 21. Americas New Psychoactive Substance Market Size Market Share by Country (2017-2022)

Table 22. Americas New Psychoactive Substance Market Size by Type (2017-2022) & ($ Millions)

Table 23. Americas New Psychoactive Substance Market Size Market Share by Type (2017-2022)

Table 24. Americas New Psychoactive Substance Market Size by Application (2017-2022) & ($ Millions)

Table 25. Americas New Psychoactive Substance Market Size Market Share by Application (2017-2022)

Table 26. APAC New Psychoactive Substance Market Size by Region (2017-2022) & ($ Millions)

Table 27. APAC New Psychoactive Substance Market Size Market Share by Region (2017-2022)

Table 28. APAC New Psychoactive Substance Market Size by Type (2017-2022) & ($ Millions)

Table 29. APAC New Psychoactive Substance Market Size Market Share by Type (2017-2022)

Table 30. APAC New Psychoactive Substance Market Size by Application (2017-2022) & ($ Millions)

Table 31. APAC New Psychoactive Substance Market Size Market Share by Application (2017-2022)

Table 32. Europe New Psychoactive Substance Market Size by Country (2017-2022) & ($ Millions)

Table 33. Europe New Psychoactive Substance Market Size Market Share by Country (2017-2022)

Table 34. Europe New Psychoactive Substance Market Size by Type (2017-2022) & ($ Millions)

Table 35. Europe New Psychoactive Substance Market Size Market Share by Type (2017-2022)

Table 36. Europe New Psychoactive Substance Market Size by Application (2017-2022) & ($ Millions)

Table 37. Europe New Psychoactive Substance Market Size Market Share by Application (2017-2022)

Table 38. Middle East & Africa New Psychoactive Substance Market Size by Region (2017-2022) & ($ Millions)

Table 39. Middle East & Africa New Psychoactive Substance Market Size Market Share by Region (2017-2022)

Table 40. Middle East & Africa New Psychoactive Substance Market Size by Type (2017-2022) & ($ Millions)

Table 41. Middle East & Africa New Psychoactive Substance Market Size Market Share by Type (2017-2022)

Table 42. Middle East & Africa New Psychoactive Substance Market Size by Application (2017-2022) & ($ Millions)

Table 43. Middle East & Africa New Psychoactive Substance Market Size Market Share by Application (2017-2022)

Table 44. Key Market Drivers & Growth Opportunities of New Psychoactive Substance

Table 45. Key Market Challenges & Risks of New Psychoactive Substance

Table 46. Key Industry Trends of New Psychoactive Substance

Table 47. Global New Psychoactive Substance Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 48. Global New Psychoactive Substance Market Size Market Share Forecast by Regions (2023-2028)

Table 49. Global New Psychoactive Substance Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 50. Global New Psychoactive Substance Market Size Market Share Forecast by Type (2023-2028)

Table 51. Global New Psychoactive Substance Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 52. Global New Psychoactive Substance Market Size Market Share Forecast by Application (2023-2028)

Table 53. Zynerba Pharmaceuticals Details, Company Type, New Psychoactive Substance Area Served and Its Competitors

Table 54. Zynerba Pharmaceuticals New Psychoactive Substance Product Offered

Table 55. Zynerba Pharmaceuticals New Psychoactive Substance Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 56. Zynerba Pharmaceuticals Main Business

Table 57. Zynerba Pharmaceuticals Latest Developments

Table 58. GW Pharmaceuticals Details, Company Type, New Psychoactive Substance Area Served and Its Competitors

Table 59. GW Pharmaceuticals New Psychoactive Substance Product Offered

Table 60. GW Pharmaceuticals Main Business

Table 61. GW Pharmaceuticals New Psychoactive Substance Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 62. GW Pharmaceuticals Latest Developments

Table 63. Teewinot Life Sciences Details, Company Type, New Psychoactive Substance Area Served and Its Competitors

Table 64. Teewinot Life Sciences New Psychoactive Substance Product Offered

Table 65. Teewinot Life Sciences Main Business

Table 66. Teewinot Life Sciences New Psychoactive Substance Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 67. Teewinot Life Sciences Latest Developments

Table 68. AusCann Details, Company Type, New Psychoactive Substance Area Served and Its Competitors

Table 69. AusCann New Psychoactive Substance Product Offered

Table 70. AusCann Main Business

Table 71. AusCann New Psychoactive Substance Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 72. AusCann Latest Developments

Table 73. Cannabics Pharmaceuticals Details, Company Type, New Psychoactive Substance Area Served and Its Competitors

Table 74. Cannabics Pharmaceuticals New Psychoactive Substance Product Offered

Table 75. Cannabics Pharmaceuticals Main Business

Table 76. Cannabics Pharmaceuticals New Psychoactive Substance Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 77. Cannabics Pharmaceuticals Latest Developments

Table 78. Tilray Details, Company Type, New Psychoactive Substance Area Served and Its Competitors

Table 79. Tilray New Psychoactive Substance Product Offered

Table 80. Tilray Main Business

Table 81. Tilray New Psychoactive Substance Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 82. Tilray Latest Developments

Table 83. Cyrelian Details, Company Type, New Psychoactive Substance Area Served and Its Competitors

Table 84. Cyrelian New Psychoactive Substance Product Offered

Table 85. Cyrelian Main Business

Table 86. Cyrelian New Psychoactive Substance Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 87. Cyrelian Latest Developments

Table 88. Anandia Laboratories Details, Company Type, New Psychoactive Substance Area Served and Its Competitors

Table 89. Anandia Laboratories New Psychoactive Substance Product Offered

Table 90. Anandia Laboratories Main Business

Table 91. Anandia Laboratories New Psychoactive Substance Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 92. Anandia Laboratories Latest Developments

Table 93. InMed Pharmaceuticals Details, Company Type, New Psychoactive Substance Area Served and Its Competitors

Table 94. InMed Pharmaceuticals New Psychoactive Substance Product Offered

Table 95. InMed Pharmaceuticals Main Business

Table 96. InMed Pharmaceuticals New Psychoactive Substance Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 97. InMed Pharmaceuticals Latest Developments

Table 98. Renew Biopharma Details, Company Type, New Psychoactive Substance Area Served and Its Competitors

Table 99. Renew Biopharma New Psychoactive Substance Product Offered

Table 100. Renew Biopharma Main Business

Table 101. Renew Biopharma New Psychoactive Substance Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 102. Renew Biopharma Latest Developments

Table 103. Cronos Group Details, Company Type, New Psychoactive Substance Area Served and Its Competitors

Table 104. Cronos Group New Psychoactive Substance Product Offered

Table 105. Cronos Group New Psychoactive Substance Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 106. Cronos Group Main Business

Table 107. Cronos Group Latest Developments

Table 108. ICC International Cannabis Details, Company Type, New Psychoactive Substance Area Served and Its Competitors

Table 109. ICC International Cannabis New Psychoactive Substance Product Offered

Table 110. ICC International Cannabis Main Business

Table 111. ICC International Cannabis New Psychoactive Substance Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 112. ICC International Cannabis Latest Developments

Table 113. Biotii Technologies Details, Company Type, New Psychoactive Substance Area Served and Its Competitors

Table 114. Biotii Technologies New Psychoactive Substance Product Offered

Table 115. Biotii Technologies Main Business

Table 116. Biotii Technologies New Psychoactive Substance Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 117. Biotii Technologies Latest Developments

List of Figures

Figure 1. New Psychoactive Substance Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global New Psychoactive Substance Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global New Psychoactive Substance Market Size Market Share by Type in 2021

Figure 7. New Psychoactive Substance in Cancer

Figure 8. Global New Psychoactive Substance Market: Cancer (2017-2022) & ($ Millions)

Figure 9. New Psychoactive Substance in Neuropathic Disorders

Figure 10. Global New Psychoactive Substance Market: Neuropathic Disorders (2017-2022) & ($ Millions)

Figure 11. New Psychoactive Substance in Spasticity

Figure 12. Global New Psychoactive Substance Market: Spasticity (2017-2022) & ($ Millions)

Figure 13. New Psychoactive Substance in Others

Figure 14. Global New Psychoactive Substance Market: Others (2017-2022) & ($ Millions)

Figure 15. Global New Psychoactive Substance Market Size Market Share by Application in 2021

Figure 16. Global New Psychoactive Substance Revenue Market Share by Player in 2021

Figure 17. Global New Psychoactive Substance Market Size Market Share by Regions (2017-2022)

Figure 18. Americas New Psychoactive Substance Market Size 2017-2022 ($ Millions)

Figure 19. APAC New Psychoactive Substance Market Size 2017-2022 ($ Millions)

Figure 20. Europe New Psychoactive Substance Market Size 2017-2022 ($ Millions)

Figure 21. Middle East & Africa New Psychoactive Substance Market Size 2017-2022 ($ Millions)

Figure 22. Americas New Psychoactive Substance Value Market Share by Country in 2021

Figure 23. Americas New Psychoactive Substance Consumption Market Share by Type in 2021

Figure 24. Americas New Psychoactive Substance Market Size Market Share by Application in 2021

Figure 25. United States New Psychoactive Substance Market Size Growth 2017-2022 ($ Millions)

Figure 26. Canada New Psychoactive Substance Market Size Growth 2017-2022 ($ Millions)

Figure 27. Mexico New Psychoactive Substance Market Size Growth 2017-2022 ($ Millions)

Figure 28. Brazil New Psychoactive Substance Market Size Growth 2017-2022 ($ Millions)

Figure 29. APAC New Psychoactive Substance Market Size Market Share by Region in 2021

Figure 30. APAC New Psychoactive Substance Market Size Market Share by Application in 2021

Figure 31. China New Psychoactive Substance Market Size Growth 2017-2022 ($ Millions)

Figure 32. Japan New Psychoactive Substance Market Size Growth 2017-2022 ($ Millions)

Figure 33. Korea New Psychoactive Substance Market Size Growth 2017-2022 ($ Millions)

Figure 34. Southeast Asia New Psychoactive Substance Market Size Growth 2017-2022 ($ Millions)

Figure 35. India New Psychoactive Substance Market Size Growth 2017-2022 ($ Millions)

Figure 36. Australia New Psychoactive Substance Market Size Growth 2017-2022 ($ Millions)

Figure 37. Europe New Psychoactive Substance Market Size Market Share by Country in 2021

Figure 38. Europe New Psychoactive Substance Market Size Market Share by Type in 2021

Figure 39. Europe New Psychoactive Substance Market Size Market Share by Application in 2021

Figure 40. Germany New Psychoactive Substance Market Size Growth 2017-2022 ($ Millions)

Figure 41. France New Psychoactive Substance Market Size Growth 2017-2022 ($ Millions)

Figure 42. UK New Psychoactive Substance Market Size Growth 2017-2022 ($ Millions)

Figure 43. Italy New Psychoactive Substance Market Size Growth 2017-2022 ($ Millions)

Figure 44. Russia New Psychoactive Substance Market Size Growth 2017-2022 ($ Millions)

Figure 45. Middle East & Africa New Psychoactive Substance Market Size Market Share by Region in 2021

Figure 46. Middle East & Africa New Psychoactive Substance Market Size Market Share by Type in 2021

Figure 47. Middle East & Africa New Psychoactive Substance Market Size Market Share by Application in 2021

Figure 48. Egypt New Psychoactive Substance Market Size Growth 2017-2022 ($ Millions)

Figure 49. South Africa New Psychoactive Substance Market Size Growth 2017-2022 ($ Millions)

Figure 50. Israel New Psychoactive Substance Market Size Growth 2017-2022 ($ Millions)

Figure 51. Turkey New Psychoactive Substance Market Size Growth 2017-2022 ($ Millions)

Figure 52. GCC Country New Psychoactive Substance Market Size Growth 2017-2022 ($ Millions)

Figure 53. Americas New Psychoactive Substance Market Size 2023-2028 ($ Millions)

Figure 54. APAC New Psychoactive Substance Market Size 2023-2028 ($ Millions)

Figure 55. Europe New Psychoactive Substance Market Size 2023-2028 ($ Millions)

Figure 56. Middle East & Africa New Psychoactive Substance Market Size 2023-2028 ($ Millions)

Figure 57. United States New Psychoactive Substance Market Size 2023-2028 ($ Millions)

Figure 58. Canada New Psychoactive Substance Market Size 2023-2028 ($ Millions)

Figure 59. Mexico New Psychoactive Substance Market Size 2023-2028 ($ Millions)

Figure 60. Brazil New Psychoactive Substance Market Size 2023-2028 ($ Millions)

Figure 61. China New Psychoactive Substance Market Size 2023-2028 ($ Millions)

Figure 62. Japan New Psychoactive Substance Market Size 2023-2028 ($ Millions)

Figure 63. Korea New Psychoactive Substance Market Size 2023-2028 ($ Millions)

Figure 64. Southeast Asia New Psychoactive Substance Market Size 2023-2028 ($ Millions)

Figure 65. India New Psychoactive Substance Market Size 2023-2028 ($ Millions)

Figure 66. Australia New Psychoactive Substance Market Size 2023-2028 ($ Millions)

Figure 67. Germany New Psychoactive Substance Market Size 2023-2028 ($ Millions)

Figure 68. France New Psychoactive Substance Market Size 2023-2028 ($ Millions)

Figure 69. UK New Psychoactive Substance Market Size 2023-2028 ($ Millions)

Figure 70. Italy New Psychoactive Substance Market Size 2023-2028 ($ Millions)

Figure 71. Russia New Psychoactive Substance Market Size 2023-2028 ($ Millions)

Figure 72. Spain New Psychoactive Substance Market Size 2023-2028 ($ Millions)

Figure 73. Egypt New Psychoactive Substance Market Size 2023-2028 ($ Millions)

Figure 74. South Africa New Psychoactive Substance Market Size 2023-2028 ($ Millions)

Figure 75. Israel New Psychoactive Substance Market Size 2023-2028 ($ Millions)

Figure 76. Turkey New Psychoactive Substance Market Size 2023-2028 ($ Millions)

Figure 77. GCC Countries New Psychoactive Substance Market Size 2023-2028 ($ Millions)